Two Sigma Advisers
AVAH icon

Two Sigma Advisers’s Aveanna Healthcare AVAH Stock Holding History

Two Sigma Advisers’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,400
Closed -$469K – 206
2025
Q4 		$469K Buy
57,400
+26,400
+85% +$238K ﹤0.01% 1811
2025
Q3 		$275K Buy
+31,000
New +$196K ﹤0.01% 2029

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $233M AUM 18.82% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Advisers's AVAH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Aveanna Healthcare (AVAH) in Q1 2026, closing a stake of 57,400 shares — an estimated $469K sold.

Two Sigma Advisers first reported a position in AVAH in Q3 2025 and held it in 2 quarters. The position peaked at $469K in Q4 2025. 198 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Aveanna Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 57,400 Aveanna Healthcare shares in Q1 2026, an estimated $469K.
  • Two Sigma Advisers first reported a position in Aveanna Healthcare in Q3 2025 and held it in 2 quarters.
  • Two Sigma Advisers's Aveanna Healthcare position peaked at $469K in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.